Skip to main content

AXIV Sinus Severe Mucus

NDC 82706-020 · VIVUNT PHARMA LLC

Generic nameAcetaminophen, Guaifenesin, Phenylephrine Hydrocloride
Dosage formCAPSULE, LIQUID FILLED
RouteORAL
Active ingredient(s)PHENYLEPHRINE HYDROCHLORIDE, GUAIFENESIN, ACETAMINOPHEN
Strength325; 200; 5 mg/1; mg/1; mg/1
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

82706-020-01 — 2 BLISTER PACK in 1 CARTON (82706-020-01) / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK

82706-020-03 — 50 POUCH in 1 CARTON (82706-020-03) / 2 CAPSULE, LIQUID FILLED in 1 POUCH

82706-020-04 — 25 POUCH in 1 CARTON (82706-020-04) / 25 CAPSULE, LIQUID FILLED in 1 POUCH

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

82688-001 — Acetaminophen Phenylephrine HCl Chlorpheniramine Maleate, 82706-007 — Acetaminophen, 82706-008 — Acetaminophen, 82706-009 — Acetaminophen, Diphenhydramine hydrochloride, 82706-010 — Acetaminophen, Caffeine, 82706-011 — Acetaminophen, Dextromethorphan Hydrobromide, 82706-012 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, 82706-013 — Dextromethorphan Hydrobromide, Guaifenesin, 82706-015 — Acetaminophen, Dextromethorphan Hydrobromide, 82706-016 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, 82706-022 — Acetaminophen, Dextromethorphan Hydrobromide, 82706-023 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, 82706-024 — Dextromethorphan Hydrobromide, Guaifenesin, 82706-025 — Acetaminophen, Phenylephrine Hydrochloride, 82725-1012 — Guaifenesin 400 mg, 82725-1023 — ACETAMINOPHEN, ASPIRIN, CAFFEINE, 82725-1024 — ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, 82725-1111 — PHENYLEPHRINE HYDROCHLORIDE, 82725-3027 — ACETAMINOPHEN, 82725-4027 — ACETAMINOPHEN, +4982 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels